KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Edwards Lifesciences (EW) Shares Outstanding (Diluted Average) (2016 - 2026)

Edwards Lifesciences has reported Shares Outstanding (Diluted Average) over the past 15 years, most recently at $585.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 2.25% year-over-year to $585.8 million; the TTM value through Dec 2025 reached $585.8 million, down 2.25%, while the annual FY2025 figure was $585.8 million, 2.25% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $585.8 million at Edwards Lifesciences, roughly flat from $587.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $631.7 million in Q3 2021 and troughed at $585.8 million in Q4 2025.
  • A 5-year average of $611.5 million and a median of $610.4 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 0.46% in 2021 and later fell 2.94% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $631.2 million in 2021, then fell by 1.11% to $624.2 million in 2022, then decreased by 2.37% to $609.4 million in 2023, then dropped by 1.66% to $599.3 million in 2024, then fell by 2.25% to $585.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for EW at $585.8 million in Q4 2025, $587.2 million in Q3 2025, and $587.9 million in Q2 2025.